VIRGINIA MARIA TJAN
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology MONTROSE, CO NPI 1104824630
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CO NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$1,946.60
- Category: General Payments
- Program years: PY2018–2024
- Record count: 96
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $891.26 across 44 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $871.26 | 43 |
| Education | $20.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $146.43 | 7 |
| E.R. Squibb & Sons, L.L.C. | $74.75 | 3 |
| Merck Sharp & Dohme Corporation | $68.25 | 3 |
| EISAI INC. | $61.61 | 3 |
| ABBVIE INC. | $53.92 | 3 |
| Daiichi Sankyo Inc. | $50.39 | 3 |
| Coherus Biosciences Inc. | $46.95 | 2 |
| Phathom Pharmaceuticals, Inc. | $44.92 | 2 |
| Incyte Corporation | $38.35 | 2 |
| PharmaEssentia USA Corporation | $38.01 | 2 |
| PFIZER INC. | $37.21 | 2 |
| Lilly USA, LLC | $36.67 | 2 |
| Janssen Biotech, Inc. | $31.72 | 2 |
| Mirati Therapeutics, Inc. | $30.59 | 2 |
| Genentech USA, Inc. | $25.64 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.33 | 1 |
| Regeneron Healthcare Solutions, Inc. | $24.33 | 1 |
| AVEO Pharmaceuticals, Inc. | $20.00 | 1 |
| Karyopharm Therapeutics Inc. | $19.21 | 1 |
| MENARINI SILICON BIOSYSTEMS, INC. | $17.98 | 1 |
By program year
Records — PY2024 (44)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.